Table 3.
AF* | Stroke*† | |||
---|---|---|---|---|
Hazard Ratio | P Value | Hazard Ratio | P Value | |
Predictor variable | ||||
Age group, y (reference = 18 to 34 years) | ||||
35 to 44 | 1.30 | 0.0010 | 1.54 | <0.0001 |
45 to 54 | 2.40 | <0.0001 | 2.41 | <0.0001 |
55 to 64 | 4.65 | <0.0001 | 3.99 | <0.0001 |
65 to 74 | 8.19 | <0.0001 | 6.56 | <0.0001 |
≥75 | 16.37 | <0.0001 | 10.82 | <0.0001 |
Sex (reference = Female) | ||||
Male | 1.32 | <0.0001 | 0.99 | 0.0765 |
Comorbid conditions used for risk stratification of cohorts, 2007 (reference=no) | ||||
Heart failure | 1.72 | <0.0001 | 1.23 | <0.0001 |
Hypertension | 1.31 | <0.0001 | 1.24 | <0.0001 |
Diabetes | 1.11 | <0.0001 | 1.25 | <0.0001 |
Coronary artery disease | 1.21 | <0.0001 | 1.04 | <0.0001 |
Chronic kidney disease | 1.23 | <0.0001 | 1.26 | <0.0001 |
Comorbid condition not used for risk stratification of cohorts, 2007 (reference=no) | ||||
Sleep apnea | 1.21 | <0.0001 | 1.14 | <0.0001 |
Symptoms | ||||
Chest pain | 1.01 | 0.0411 | 1.27 | <0.0001 |
Dizziness | 1.07 | <0.0001 | 1.40 | <0.0001 |
Palpitations | 1.46 | <0.0001 | 1.07 | <0.0001 |
Tachycardia unspecified | 1.19 | <0.0001 | 1.13 | <0.0001 |
Shortness of breath | 1.16 | <0.0001 | 1.13 | <0.0001 |
Respiratory—other | 1.01 | <0.0001 | 1.12 | <0.0001 |
Respiratory—unspecified | 1.09 | 0.6292 | 1.09 | 0.0033 |
Indicators of stroke timing† (reference=no) | ||||
AF event >14 d before stroke event | — | — | 16.2 | <0.0001 |
AF event within 14 d of stroke event | — | — | 21.9 | <0.0001 |
Oral anticoagulation use >14 d before stroke event | — | — | 0.6 | <0.0001 |
d indicates days; y, years.
Estimates for each risk factor were adjusted for geographic region, medications, and use of internal/external electrocardiographic recording devices, in addition to all other risk factors shown in the table.
Stroke model also included indicators of stroke timing.